Cargando…

Clinical considerations for patients with diabetes in times of COVID-19 epidemic

Detalles Bibliográficos
Autores principales:	Gupta, Ritesh, Ghosh, Amerta, Singh, Awadhesh Kumar, Misra, Anoop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102582/ https://www.ncbi.nlm.nih.gov/pubmed/32172175 http://dx.doi.org/10.1016/j.dsx.2020.03.002

Ejemplares similares

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
por: Ghosh, Amerta, et al.
Publicado: (2020)

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020)

Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
por: Misra, Anoop, et al.
Publicado: (2021)

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
por: Ghosh, Amerta, et al.
Publicado: (2020)

Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India
por: Gupta, Ritesh, et al.
Publicado: (2020)

COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes
por: Ghosh, Amerta, et al.
Publicado: (2020)

Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report
por: Ghosh, Amerta, et al.
Publicado: (2021)

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Letter to the editor in response to article: “Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)
por: Gupta, Ritesh
Publicado: (2020)

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases
por: Mishra, Abha, et al.
Publicado: (2021)

Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India
por: Sabharwal, Mudit, et al.
Publicado: (2022)

High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
por: Mittal, Juhi, et al.
Publicado: (2021)

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
por: Gupta, Ritesh, et al.
Publicado: (2020)

“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis
por: Nassar, Mahmoud, et al.
Publicado: (2023)

Diabetes and COVID-19: evidence, current status and unanswered research questions
por: Gupta, Ritesh, et al.
Publicado: (2020)

Molnupiravir in COVID-19: A systematic review of literature
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19()
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
por: Tyagi, Kanika, et al.
Publicado: (2021)

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research
por: Gupta, Ritesh, et al.
Publicado: (2020)

Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study
por: Ghosh, Amerta, et al.
Publicado: (2021)

Management of diabetes mellitus through teleconsultation during COVID-19 and similar scenarios - Guidelines from Indian Council of Medical Research (ICMR) expert group
por: Sarveswaran, Gokul, et al.
Publicado: (2021)

COVID-19 associated mucormycosis: A Descriptive Multisite Study from India
por: Gupta, Ritesh, et al.
Publicado: (2021)

Letter to the editor in response to article: “Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)
por: Hussain, Akhtar, et al.
Publicado: (2020)

Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)"
por: Home, Philip
Publicado: (2020)

Clinical considerations for patients with diabetes in times of COVID-19 pandemic
por: Hussain, Akhtar, et al.
Publicado: (2020)

Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution
por: Misra, Anoop
Publicado: (2020)

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges
por: Pal, Rimesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j783odga6d0g0258o7hpdck307